[18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases.

Saved in:
Bibliographic Details
Title: [18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases.
Authors: Porter JC; CITR, UCL Respiratory, University College London, London, United Kingdom; joanna.porter@ucl.ac.uk.; Interstitial Lung Disease Centre, University College London Hospital, London, United Kingdom., Ganeshan B; Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom., Win T; Lister Hospital, North East Herts Trust, Stevenage, United Kingdom., Fraioli F; Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom., Khan S; Research Department of Pathology, University College London, and Department of Histopathology, University College London Hospital, London, United Kingdom; and., Rodriguez-Justo M; Research Department of Pathology, University College London, and Department of Histopathology, University College London Hospital, London, United Kingdom; and., Endozo R; Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom., Shortman RI; Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom., Hoy LR; Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom., Maher TM; Keck School of Medicine, University of Southern California, Los Angeles, California., Groves AM; Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Apr 01; Vol. 65 (4), pp. 617-622. Date of Electronic Publication: 2024 Apr 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.123.266445